Location History:
- Kita-ku, JP (2013)
- Tokyo, JP (2021 - 2023)
Company Filing History:
5 out of 950 
3 out of 4,948 
2 out of 168 
Years Active: 2013-2023
Title: Terutoshi Maeda: Innovator in Antibody Formulations
Introduction
Terutoshi Maeda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of stable antibody formulations. With a total of 5 patents to his name, Maeda's work focuses on enhancing the stability and efficacy of antibody-containing liquid formulations.
Latest Patents
Maeda's latest patents include innovative solutions for high concentration antibody-containing liquid formulations. One of the key problems he addresses is the need for a humanized anti-IL-6 receptor antibody formulation suitable for subcutaneous administration. His formulations are designed to prevent dimerization or deamidation during long-term storage. The stable antibody-containing liquid formulations are characterized by the inclusion of arginine and histidine buffer. This method effectively inhibits deamidation or dimerization in concentrated liquid formulations, ensuring the integrity of the antibodies.
Career Highlights
Throughout his career, Terutoshi Maeda has worked with notable companies in the pharmaceutical industry, including Chugai Seiyaku Kabushiki Kaisha and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his expertise in developing advanced biopharmaceutical products.
Collaborations
Maeda has collaborated with esteemed colleagues such as Toshiyuki Morichika and Daisuke Kameoka. These partnerships have further enriched his research and development efforts in the field of antibody formulations.
Conclusion
Terutoshi Maeda's innovative work in antibody formulations has made a significant impact on the biopharmaceutical industry. His patents reflect a commitment to improving the stability and effectiveness of therapeutic antibodies, paving the way for advancements in medical treatments.